Date published: 2026-5-30

1-800-457-3801

SCBT Portrait Logo
Seach Input

TSTD1 Inhibitors

TSTD1 inhibitors are a class of chemical compounds specifically designed to inhibit the activity of thiosulfate sulfurtransferase-like domain-containing 1 (TSTD1), an enzyme involved in sulfur metabolism. TSTD1, like other sulfurtransferases, plays a key role in catalyzing the transfer of sulfur from thiosulfate to various acceptor molecules. This process is essential for multiple biochemical pathways related to sulfur-containing compounds, which are involved in cellular redox regulation, detoxification processes, and the synthesis of key biomolecules. TSTD1 inhibitors block the catalytic activity of this enzyme, preventing it from facilitating sulfur transfer. As a result, these inhibitors disrupt critical metabolic pathways that depend on sulfur exchange, leading to changes in the overall balance of sulfur-related biochemical processes within the cell.

The design of TSTD1 inhibitors is typically focused on molecules that can bind to the active site of the enzyme, where sulfur transfer occurs, or to allosteric sites that influence enzyme conformation and function. These inhibitors may mimic natural substrates or transition states of sulfur-donor molecules, allowing them to effectively compete with the enzyme's normal substrates. Specificity is a crucial aspect of designing TSTD1 inhibitors because sulfurtransferases share common structural features. Researchers often aim to design inhibitors that are selective for TSTD1 by targeting unique aspects of its active site or structural motifs. By studying TSTD1 inhibitors, scientists can better understand the enzyme's specific role in sulfur metabolism, as well as gain insights into the broader regulatory mechanisms governing sulfur-dependent biochemical pathways in various cellular contexts.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

rac 2-Aminothiazoline-4-carboxylic Acid-13C,15N2

1346599-59-4sc-480610
1 mg
$396.00
(0)

rac 2-Aminothiazoline-4-carboxylic Acid-13C,15N2, an inhibitor of cystathionine gamma-lyase, indirectly influences TSTD1 by disrupting the cysteine biosynthesis pathway. Inhibition of cystathionine gamma-lyase leads to reduced availability of cysteine, affecting the overall thiosulfate-thiol sulfurtransferase activity of TSTD1 and impeding its function in sulfide oxidation processes.